Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF

被引:1712
作者
Holash, J
Maisonpierre, PC
Compton, D
Boland, P
Alexander, CR
Zagzag, D
Yancopoulos, GD
Wiegand, SJ
机构
[1] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
[2] NYU, Med Ctr, Kaplan Canc Ctr, Dept Pathol,Microvasc & Mol Neurooncol Lab, New York, NY 10016 USA
关键词
D O I
10.1126/science.284.5422.1994
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In contrast with the prevailing view that most tumors and metastases begin as avascular masses, evidence is presented here that a subset of tumors instead initially grows by coopting existing host vessels. This coopted host vasculature does not immediately undergo angiogenesis to support the tumor but instead regresses, leading to a secondarily avascular tumor and massive tumor cell loss. Ultimately, however, the remaining tumor is rescued by robust angiogenesis at the tumor margin. The expression patterns of the angiogenic antagonist angiopoietin-2 and of pro-angiogenic vascular endothelial growth factor (VEGF) suggest that these proteins may be critical regulators of this balance between vascular regression and growth.
引用
收藏
页码:1994 / 1998
页数:5
相关论文
共 41 条
[11]   WHAT IS THE EVIDENCE THAT TUMORS ARE ANGIOGENESIS DEPENDENT [J].
FOLKMAN, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (01) :4-6
[12]   Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate [J].
Goldman, CK ;
Kendall, RL ;
Cabrera, G ;
Soroceanu, L ;
Heike, Y ;
Gillespie, GY ;
Siegal, GP ;
Mao, XZ ;
Bett, AJ ;
Huckle, WR ;
Thomas, KA ;
Curiel, DT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) :8795-8800
[13]   Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis [J].
Hanahan, D ;
Folkman, J .
CELL, 1996, 86 (03) :353-364
[14]  
HOLASH J, UNPUB
[15]   DORMANCY OF MICROMETASTASES - BALANCED PROLIFERATION AND APOPTOSIS IN THE PRESENCE OF ANGIOGENESIS SUPPRESSION [J].
HOLMGREN, L ;
OREILLY, MS ;
FOLKMAN, J .
NATURE MEDICINE, 1995, 1 (02) :149-153
[16]   MOLECULAR-CLONING AND CHARACTERIZATION OF MOUSE TIE AND TEK RECEPTOR TYROSINE KINASE GENES AND THEIR EXPRESSION IN HEMATOPOIETIC STEM-CELLS [J].
IWAMA, A ;
HAMAGUCHI, I ;
HASHIYAMA, M ;
MURAYAMA, Y ;
YASUNAGA, K ;
SUDA, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 195 (01) :301-309
[17]  
KIM KJ, 1993, NATURE, V362, P741
[18]   Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis [J].
Maisonpierre, PC ;
Suri, C ;
Jones, PF ;
Bartunkova, S ;
Wiegand, S ;
Radziejewski, C ;
Compton, D ;
McClain, J ;
Aldrich, TH ;
Papadopoulos, N ;
Daly, TJ ;
Davis, S ;
Sato, TN ;
Yancopoulos, GD .
SCIENCE, 1997, 277 (5322) :55-60
[19]  
MAISONPIERRE PC, 1993, ONCOGENE, V8, P1631
[20]  
Millauer B, 1996, CANCER RES, V56, P1615